GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Alkem Laboratories Ltd (BOM:539523) » Definitions » 5-Year Share Buyback Ratio

Alkem Laboratories (BOM:539523) 5-Year Share Buyback Ratio : 0.00% (As of Dec. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Alkem Laboratories 5-Year Share Buyback Ratio?

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

5-Year Share Buyback Ratio measures the average annual proportion of a company's outstanding shares repurchased over the past five years. It is calculated as the annualized percentage change in shares outstanding from five years ago to the current year. A positive ratio may indicate share buybacks over the period, while a zero or negative ratio may reflect no repurchases or potential share issuance. Alkem Laboratories's current 5-Year Share Buyback Ratio was 0.00%.

BOM:539523's 5-Year Share Buyback Ratio is not ranked *
in the Drug Manufacturers industry.
Industry Median: -3
* Ranked among companies with meaningful 5-Year Share Buyback Ratio only.

Competitive Comparison of Alkem Laboratories's 5-Year Share Buyback Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Alkem Laboratories's 5-Year Share Buyback Ratio, along with its competitors' market caps and 5-Year Share Buyback Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Alkem Laboratories's 5-Year Share Buyback Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Alkem Laboratories's 5-Year Share Buyback Ratio distribution charts can be found below:

* The bar in red indicates where Alkem Laboratories's 5-Year Share Buyback Ratio falls into.


;
;

Alkem Laboratories 5-Year Share Buyback Ratio Calculation

This is the annualized percentage change in shares outstanding from five years ago to the current year. The annualized percentage change is calculated with least-square regression based on the latest six years of annual data on Shares Outstanding (EOP).

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.


Alkem Laboratories (BOM:539523) 5-Year Share Buyback Ratio Explanation

A negative number means the company might be issuing new shares. A positive number indicates that the company is buying back shares.


Be Aware

Investors usually like share buybacks. But as pointed by Warren Buffett, only if a company buys back shares at the prices below the stock's intrinsic value, it rewards remaining shareholders. If a company buys its overvalued stocks back, it destroys shareholder value.


Alkem Laboratories 5-Year Share Buyback Ratio Related Terms

Thank you for viewing the detailed overview of Alkem Laboratories's 5-Year Share Buyback Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Alkem Laboratories Business Description

Traded in Other Exchanges
Address
Senapati Bapat Marg, Alkem House, Devashish Building, Lower Parel, Mumbai, MH, IND, 400 013
Alkem Laboratories Ltd is an Indian pharmaceutical company engaged in the development, manufacture, and sale of pharmaceutical and nutraceutical products. The company produces branded generics, generic drugs, active pharmaceutical ingredients (APIs) and nutraceuticals in acute and chronic therapeutic areas, such as anti-infective, pain and analgesics, vitamins/minerals/nutrients, cardiac and Diabetology, Gynecology, neuro/central nervous system, dermatology, anti-diabetes, anti-osteoporosis, cardiovascular, and muscle relaxants, which are marketed in Indian and International markets. It operates through the pharmaceutical business segment.

Alkem Laboratories Headlines

No Headlines